|On January 20, Mihir Taneja, CEO of GeoPharma, Inc. (Nasdaq: GORX - News) updated the investment community in an all-new interview with www.wallst.net. Interview highlights include detailed discussions on the following topics:|
- current manufacturing capabilities, and customers
- focus on the manufacturing of generic-drugs
- industry trends, and potential for growth
- key drivers behind recent earnings surge
- competitive edge in the industry
- upcoming strategic and financial milestones
To hear the interviews in their entirety, visit wallst.net , and click on "Interviews/Podcasts." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews/Podcasts" page or by entering the respective company's ticker symbol in the Search Archive window at the bottom of the "Interviews/Podcasts" page.